These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 1070009)
1. Studies of human myasthenia gravis: electrophysiological and ultrastructural evidence compatible with antibody attachment to acetylcholine receptor complex. Rash JE; Albuquerque EX; Hudson CS; Mayer RF; Satterfield JR Proc Natl Acad Sci U S A; 1976 Dec; 73(12):4584-8. PubMed ID: 1070009 [TBL] [Abstract][Full Text] [Related]
2. Myasthenia gravis: further electrophysiological and ultrastructural analysis of transmission failure in the mouse passive transfer model. Toyka KV; Birnberger KL; Anzil AP; Schlegel C; Besinger U; Struppler A J Neurol Neurosurg Psychiatry; 1978 Aug; 41(8):746-53. PubMed ID: 210263 [TBL] [Abstract][Full Text] [Related]
3. Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice. Klooster R; Plomp JJ; Huijbers MG; Niks EH; Straasheijm KR; Detmers FJ; Hermans PW; Sleijpen K; Verrips A; Losen M; Martinez-Martinez P; De Baets MH; van der Maarel SM; Verschuuren JJ Brain; 2012 Apr; 135(Pt 4):1081-101. PubMed ID: 22396395 [TBL] [Abstract][Full Text] [Related]
4. The motor end plate in myasthenia gravis and in experimental autoimmune myasthenia gravis. A quantitative ultrastructural study. Engel AG; Tsujihata M; Lindstrom JM; Lennon VA Ann N Y Acad Sci; 1976; 274():60-79. PubMed ID: 1066997 [TBL] [Abstract][Full Text] [Related]
5. Freeze fracture studies of human neuromuscular junctions. Membrane alterations observed in myasthenia gravis. Rash JE; Hudson CS; Graham WF; Mayer RF; Warnick JE; Albuquerque EX Lab Invest; 1981 Jun; 44(6):519-30. PubMed ID: 7230737 [TBL] [Abstract][Full Text] [Related]
6. Ultrastructural localization of the acetylcholine receptor in myasthenia gravis and in its experimental autoimmune model. Engel AG; Lindstrom JM; Lambert EH; Lennon VA Neurology; 1977 Apr; 27(4):307-15. PubMed ID: 557772 [TBL] [Abstract][Full Text] [Related]
7. The immunopathological basis of acetylcholine receptor deficiency in myasthenia gravis. Engel AG Prog Brain Res; 1979; 49():423-34. PubMed ID: 515440 [No Abstract] [Full Text] [Related]
8. Experimental autoimmune myasthenia gravis: a sequential and quantitative study of the neuromuscular junction ultrastructure and electrophysiologic correlations. Engel AG; Tsujihata M; Lambert EH; Lindstrom JM; Lennon VA J Neuropathol Exp Neurol; 1976; 35(5):569-87. PubMed ID: 956872 [TBL] [Abstract][Full Text] [Related]
9. Ultrastructural localization of the terminal and lytic ninth complement component (C9) at the motor end-plate in myasthenia gravis. Sahashi K; Engel AG; Lambert EH; Howard FM J Neuropathol Exp Neurol; 1980 Mar; 39(2):160-72. PubMed ID: 7373347 [TBL] [Abstract][Full Text] [Related]
10. Ultrastructural localization of acetylcholine receptor at the motor endplate: myasthenia gravis and other neuromuscular diseases. Tsujihata M; Hazama R; Ishii N; Ide Y; Takamori M Neurology; 1980 Nov; 30(11):1203-11. PubMed ID: 7191515 [TBL] [Abstract][Full Text] [Related]
11. Immune complexes (IgG and C3) at the motor end-plate in myasthenia gravis: ultrastructural and light microscopic localization and electrophysiologic correlations. Engel AG; Lambert EH; Howard FM Mayo Clin Proc; 1977 May; 52(5):267-80. PubMed ID: 870771 [TBL] [Abstract][Full Text] [Related]
12. An electrophysiological and morphological study of the neuromuscular junction in patients with myasthenia gravis. Albuquerque EX; Rash JE; Mayer RF; Satterfield JR Exp Neurol; 1976 Jun; 51(3):536-63. PubMed ID: 179836 [No Abstract] [Full Text] [Related]
13. [Histochemical findings of and fine structural changes in motor endplates in diseases with neuromuscular transmission abnormalities]. Yoshimura T; Motomura M; Tsujihata M Brain Nerve; 2011 Jul; 63(7):719-27. PubMed ID: 21747142 [TBL] [Abstract][Full Text] [Related]
14. The pathogenesis of myasthenia gravis. Heilbronn E; Stålberg E J Neurochem; 1978 Jul; 31(1):5-11. PubMed ID: 209148 [No Abstract] [Full Text] [Related]
15. [Disorders of receptor function as a pathogenetic principle in myasthenia gravis]. Toyka KV Internist (Berl); 1988 Jun; 29(6):414-9. PubMed ID: 3042682 [No Abstract] [Full Text] [Related]
16. Acetylcholine release in myasthenia gravis: regulation at single end-plate level. Plomp JJ; Van Kempen GT; De Baets MB; Graus YM; Kuks JB; Molenaar PC Ann Neurol; 1995 May; 37(5):627-36. PubMed ID: 7755358 [TBL] [Abstract][Full Text] [Related]
17. Congenital myasthenic syndromes: II. Syndrome attributed to abnormal interaction of acetylcholine with its receptor. Uchitel O; Engel AG; Walls TJ; Nagel A; Atassi MZ; Bril V Muscle Nerve; 1993 Dec; 16(12):1293-301. PubMed ID: 8232384 [TBL] [Abstract][Full Text] [Related]
19. Ultrastructural localization of immune complexes (IgG and C3) at the end-plate in experimental autoimmune myasthenia gravis. Sahashi K; Engel AG; Linstrom JM; Lambert EH; Lennon VA J Neuropathol Exp Neurol; 1978; 37(2):212-23. PubMed ID: 147324 [TBL] [Abstract][Full Text] [Related]
20. Myasthenia gravis: a personal view of pathogenesis and mechanism, part 2. Simpson JA Muscle Nerve; 1978; 1(2):151-6. PubMed ID: 220530 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]